Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

GN Store Nord Q2 profit decreases

GN Store Nord A/S, a manufacturer of hearing aids and diagnostic audiological instrumentation, has reported that profit for the second quarter of 2015 was DKK77 million, or DKK0.50 per diluted share, compared to DKK190 million, or DKK1.16 per diluted share, for the same quarter of 2014...more >>

Sobi and Menarini receive marketing authorization for SJIA drug in Australia

Swedish Orphan Biovitrum AB, or Sobi, a specialty pharmaceutical company, and A. Menarini Australia Pty Ltd have received marketing authorization for Kineret, indicated for the treatment of systemic juvenile idiopathic arthritis, or SJIA, in Australia...more >>

Immunomedics receives new US patent for antibody immunoconjugates

Immunomedics, Inc., a clinical-stage biopharmaceutical company, has received a new US patent for a family of antibody-SN-38 immunoconjugates with a CL2A linker...more >>

Immunomedics Q4 net loss increases

Immunomedics, Inc., a clinical-stage biopharmaceutical company, has reported that net loss attributable to stockholders for the fourth quarter ended June 30, 2015 was $12.4 million, or $0.13 loss per share, compared to a net loss attributable to stockholders of $11.85 million, or $0.13 loss per share, for the same quarter ended June 30, 2014...more >>